Quentin A. Howlett-Prieto

Internal Medicine

5841 S. Maryland Ave.
M/c 7082
Chicago, IL 60637

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis.

Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis.

Journal: PloS one

Published: November 23, 2024

T1 mapping from routine 3D T1-weighted inversion recovery sequences in clinical practice: comparison against reference inversion recovery fast field echo T1 scans and feasibility in multiple sclerosis.

T1 mapping from routine 3D T1-weighted inversion recovery sequences in clinical practice: comparison against reference inversion recovery fast field echo T1 scans and feasibility in multiple sclerosis.

Journal: Neuroradiology

Published: January 21, 2024

Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles.

Corrigendum: Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: gene expression and protein profiles.

Journal: Frontiers in neurology

Published: June 23, 2023

Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1a.

Prolonged Interferon-Stimulated Gene and Protein Signatures in Multiple Sclerosis Induced by PEGylated IFN-β-1a Compared to Non-PEGylated IFN-β-1a.

Journal: Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research

Published: March 03, 2023

Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles.

Adaptive and innate immune responses in multiple sclerosis with anti-CD20 therapy: Gene expression and protein profiles.

Journal: Frontiers in neurology

Published: February 03, 2023

Inter-rater agreement for the annotation of neurologic signs and symptoms in electronic health records.

Inter-rater agreement for the annotation of neurologic signs and symptoms in electronic health records.

Journal: Frontiers in digital health

Published: October 20, 2022

Subtypes of relapsing-remitting multiple sclerosis identified by network analysis.

Subtypes of relapsing-remitting multiple sclerosis identified by network analysis.

Journal: Frontiers in digital health

Published: October 06, 2022

Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis.

Increased Percentage of CD8+CD28- Regulatory T Cells With Fingolimod Therapy in Multiple Sclerosis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 09, 2022

Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis.

Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: March 30, 2021

Modulation of immune responses by bile acid receptor agonists in myasthenia gravis.

Modulation of immune responses by bile acid receptor agonists in myasthenia gravis.

Journal: Journal of neuroimmunology

Published: July 22, 2020

Vitamin D enhances responses to interferon-β in MS.

Vitamin D enhances responses to interferon-β in MS.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: April 08, 2019

Showing 1-11 of 11

Last Updated: 09/26/2026